Cheng-Chang CHANG
Adjunct Professor of OBGYN at National Defense Medical Center- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Betty Liu on Career Success
LinkedInApr, 2022- Nov, 2024 -
Drug and Medical Device Development: A Strategic Approach
Massachusetts Institute of TechnologyJan, 2022- Nov, 2024 -
Academic Teaching Rank Accreditation Certification Professor
Minister of Education, TaiwanFeb, 2021- Nov, 2024 -
Physician
Ministry of Health and Welfare, TaiwanDec, 1994- Nov, 2024 -
Board License
Asian-Pacific Association of Gynecologic EndoscopyDec, 2010- Nov, 2024 -
Board License
Taiwan Association of Minimal Invasive GynecologyDec, 2010- Nov, 2024 -
Board License
Taiwan Association of Obstetrics and GynecologyDec, 2000- Nov, 2024 -
Board License
Taiwan association of Gynecologic OncologyMay, 2012- Nov, 2024
Experience
-
National Defense Medical Center
-
Higher Education
-
1 - 100 Employee
-
Adjunct Professor of OBGYN
-
Aug 2021 - Present
• Strong communication skills to assist teams in responses to global regulator requests; capable of articulating responses in clear, concise language to audiences at all levels; experience updating Clinical Evaluation Reports. • Exceptional project management, planning, decision-making, negotiation, and change management skills; proficient in balancing product and enterprise risks in decision making. • Able to leverage a strong understanding of the da Vinci S/Si/Xi system and clinical applications in gynecologic surgery; History of interfacing across departments to inform and consult teams on regulatory post-market surveillance and investigations, quality systems, and regulatory compliance. Show less
-
-
-
Guzip Biomarkers Corp.
-
Taiwan
-
Biotechnology Research
-
1 - 100 Employee
-
Medical Consultant
-
Jul 2018 - Jun 2022
I provided the scientific background of molecular Pap smear in endometrial cancer detection and communicated with researchers and stakeholders to facilitate a clinical trial in Taiwan. Furthermore, I assisted in pre-launch, launch, & post-marketing medical strategy development, advisory boards, strategic essential opinion leader engagement, and review of investigator-initiated study requests. I provided the scientific background of molecular Pap smear in endometrial cancer detection and communicated with researchers and stakeholders to facilitate a clinical trial in Taiwan. Furthermore, I assisted in pre-launch, launch, & post-marketing medical strategy development, advisory boards, strategic essential opinion leader engagement, and review of investigator-initiated study requests.
-
-
-
-
Director, Cancer Center
-
Oct 2020 - Jul 2021
In this position, I applied my leadership, communication, and organizational skills to guide 11 work teams comprising medical oncologists, surgical oncologists, clinical researchers, and clinical assistants. My leadership covers the entire spectrum of cancer care services at the Center. Measuring clinical results, verifying data, and reviewing key performance indicators for the National Health Bureau of Taiwan were just a few of my focuses. I administered a $US 1.7M annual grant budget.
-
-
Department Chairman and Professor of Obstetrics and Gynecology
-
Nov 2018 - Jul 2021
I collaborated with cross-functional leaders to found the robotic gynecologic surgery training center. I oversaw 25 personnel to incorporate Intuitive da Vinci company and trained ten physicians. The two classes I taught per program across ten programs educated 120 medical school students annually. I also partnered with a coworker to pioneer a prenatal cardiology training program with a $US 700,000 budget and enrolled 500 newborns in the program. I secured $US 1.2M in grant funding from the Ministry of Science and Technology. I applied the funds to lead three translational research teams to discover unique biomarkers for potential therapeutic targets of ovarian cancer. In this position, I authored more than ten publications on ovarian cancer. I led 12 research projects and six Phase 1 through 3 clinical studies with $120M in funding. Show less
-
-
Division Director and Associate Professor of Gynecologic Oncology
-
Jan 2015 - Oct 2018
My first Director position included two roles as Division Director and Associate Professor. I mentored 16 attending physicians and recommended treatments for gynecologic cancer patients with endometrial, ovarian, cervical, vulva, and vaginal cancer and gestational trophoblastic disease. As the Principal Investigator for the Laboratory of Epigenetics of Gynecologic Oncology.
-
-
-
-
Attending Physician and Assistant Professor at Department of Obstetrics and Gynecology
-
Aug 2001 - Dec 2014
My job responsibilities included clinical services of the patients of OBS/GYN. I delivered 3000+ newborns and performed 1500+ gynecological surgeries( laparoscopic and robotics). I completed the full course training in gynecologic oncology and minimally invasive surgery. I went to Chattanooga, TN, and Sunnyvale, CA, to train laparoscopic pelvic reconstruction and robotic surgery in 2003 and 2004. I accomplished the first robotic gynecologic surgery in Taiwan in 2005, published in the TJOG. In this period, my research interest started in gynecologic cancer epigenetics. I also completed the Ph.D. degree from 2009 to 2015. Show less
-
-
Resident Doctor at Department of Obstetrics and Gynecology
-
Aug 1996 - Jul 2001
-
-
-
Army Airborne Special Operations Command
-
P’ingtung, Taiwan
-
Military Medical Officer (Lieutenant)
-
Aug 1994 - Jul 1996
-
-
Education
-
National Defense Medical Center
Doctor of Philosophy - PhD, Translational Medicine of Cancer Epigenetics -
National Defense Medical Center
Doctor of Medicine - MD, Medicine